Alfaisal Scholar Program in Research Excellence
Journal Clubs
ASPiRE Overview
The Alfaisal Scholar Program in Research Excellence (ASPiRE) is an in-house developed program that offers participants a unique and immersive experience in medical education, basic and clinical research. The ASPiRE program contributes to Alfaisal University College of Medicine's vision in preparing physicians who actively contribute to medical research.
Journal Club Overview
The ASPiRE Journal Clubs are interactive sessions that provide students with the opportunity to better understand the different sections of a research paper by aiding with increasing proficiency in reading, analyzing, and critiquing scientific literature. By participating in the journal club, students will not only be able to work on their presentation skills but will also be confident reading and analyzing any given research article they come across in the future. Having a good background in research is very crucial for every medical student and what better way to begin this journey than through participating in journal clubs!
Target Audience
Medical students from all universities
Venue
On-campus at Alfaisal University
Journal Club 1 (AY 2022-23)
Article for Discussion
miR-23b-3p rescues cognition in Alzheimer’s disease by reducing tau phosphorylation and apoptosis via GSK-3b signaling pathways
Chair of the Session
Dr. Ahmed Yaqinuddin
Vice Dean of Research & Graduate Studies
Chair of Graduate Programs
Associate Professor of Anatomy and Cell Biology, Alfaisal University, College of Medicine
Ahmed Yaqinuddin, MBBS, PhD, FRCP (Edin) is a Senior Scientist and Associate Professor of Anatomy and Cell Biology. He is also a founding faculty member of Alfaisal University College of Medicine. He currently serves as the Vice Dean for Graduate Studies and Research at the College of Medicine, Alfaisal University. Dr. Ahmed has authored more than 60 papers in indexed, highly reputed peer-reviewed journals. He has received several grants of about SAR 4 million over the years from both internal and external funding bodies including KACST and Saudi Ministry of Health. He has also authored a couple book chapters and presented his work in numerous international conferences in symposia. His research interests include DNA methylation, biomarkers, COVID-19 research, and medical education research. He is also passionate about developing innovative teaching and learning methodologies. Several of his innovative ideas have been published and are now adopted within the medical curriculum of Alfaisal University.
Journal Club 2 (AY 2022-23)
Article for Discussion
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy
Chair of the Session
Prof. Imad Tleyjeh
Consultant and Head of the Infectious Diseases Division at King Fahad Medical City
Adjunct Faculty with the Division of Infectious Diseases and Public Health and the Division of Epidemiology,
Mayo Clinic, College of Medicine and Sciences, Rochester, USA
Prof. Imad Tleyjeh is a Consultant of Infectious Diseases at King Fahd Medical City in Riyadh, Saudi Arabia. He is an Adjunct Faculty with the Division of Infectious Diseases and Public Health and the Division of Epidemiology at Mayo Clinic College of Medicine and Sciences, Rochester, USA, where he also holds the appointment of Professor of Medicine and Epidemiology. He is also an Adjunct Professor of Medicine and Epidemiology at Alfaisal University.
Prof. Tleyjeh is a clinician-investigator who has written multiple book chapters and has around 125 peer-reviewed publications in high-impact journals with more than 30,000 citations. He is a certified instructor for the Medical Education Research Certificate (MERC) of the American Association of Medical Colleges (AAMC). He is also a member of the guidelines writing committee for Infective Endocarditis, at the American Heart Association.
Journal Club 3 (AY 2022-23)
Article for Discussion
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers
Chair of the Session
Prof. Ziad Memish
Senior Consultant of Infectious Diseases & Director of Research & Innovation Center at King Saud Medical City, Ministry of Health
Professor at the College of Medicine in Alfaisal University, Riyadh, Saudi Arabia
Adjunct Professor in the Hubert Department of Global Health, Rollins School of Public Health, Emory University, Georgia, USA.
Dr. Ziad is widely recognized as a pioneer in Mass Gathering Medicine and Infection Control & established the WHO collaborating center for mass gathering medicine in the Ministry of Health and WHO Collaborating Center for Infection Control in the Saudi Ministry of National Guard (Health Affairs). He was the first Deputy Minister of health for public health, KSA (2009-2014). He sits on many WHO advisory panels including the WHO IHR Emergency Committee for COVID-19, WHO SAGE Working Group on COVID-19 vaccines, WHO Strategic Technical Advisory Group on Infectious Hazards, the WHO Eastern Mediterranean Region Technical advisory group on COVID-19 and chair of the WHO Regional Technical Advisory Committee on vaccinations.
He has presented many abstracts and plenary talks internationally and published more than 750 peer-reviewed papers and book chapters. He is the editor-in-chief of 2 journals: Journal of Epidemiology & Global Health & Dr. Sulaiman Alhabib Medical Journal both published by Springer-Nature. He has been recognized as a “Highly Cited Researchers” for his exceptional research performance by the production of multiple highly cited papers (those that rank in the top 1% by citation in the field) by the Web of Science (Clarivate Analytics) 4 years in a row 2018-2021.
Journal Club 4 (AY 2022-23)
Article for Discussion
Effect of Awake Prone Positioning on Endotracheal Intubation in Patients With COVID-19 and Acute Respiratory Failure- A Randomized Clinical Trial
Chair of the Session
Prof. Hala Tamim
Ph.D. Epidemiology, Masters in Public Health
Professor, School of Kinesiology and Health Science, York University, Ontario, Canada
Prof. Hala is a Professor in the School of Kinesiology and Health Science at York University and holds an adjunct faculty position in the Department of Community Health and Epidemiology at Dalhousie University. She has a Ph.D. in epidemiology from McGill University and a Master’s in Public Health from Emory University. She has over 20 years of professional teaching and training experience.
She has extensive expertise in research methods and statistical analyses and has managed several community-based and multi-center projects. Prof. Hala’s research interests are numerous with a major focus on maternal and child health.
Journal Club 5 (AY 2022-23)
Article for Discussion
Death and Chronic Disease Risk Associated With Poor Life Satisfaction: A Population-Based Cohort Study
Chair of the Session
Prof. Ashraf Elmetwally
Professor of Epidemiology,
King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia
Associate Editor, BMC Health Services Research Journal Docent of Epidemiology, Tampere University, Finland
Professor Ashraf Elmetwally is an Egyptian medical doctor with a Ph.D. in Epidemiology and Biostatistics from Tampere University in Finland. After finishing his residency program in Rheumatology and Rehabilitation Medicine and the theoretical part of his Ph.D. in Epidemiology, he worked as an epidemiologist at the Rheumatism Foundation Hospital in Finland (2003-2005), as a lecturer in epidemiology at the University of Aberdeen, UK (2006-2008).
After earning his Ph.D. in 2009, he went on to work as a faculty and program coordinator of the health sciences program at Sharjah Higher colleges (2009-2011) and then joined the College of Public Health and Health Informatics at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh, Saudi Arabia, as an assistant professor (2011-2015), associate professor (2016-2020) then full professor (2020 till present) of Epidemiology. Prof. Ashraf also earned the academic title of Docent from Tampere University, Finland, in 2016.
He has seven years of experience (2014-2020) as a director of the MPH Master program in Epidemiology and Biostatistics at KSAU-HS. He teaches basic and advanced courses in epidemiology and biostatistics and enjoys the experience of online education. He has around 100 publications in peer-reviewed medical journals and 4 book chapters. His research interests include clinical and population-based epidemiology, pharmaceutical research, pain and musculoskeletal diseases, medical questionnaire validation, systematic reviews, and meta-analyses. Prof. Ashraf was honored with some research and teaching awards, including the "Young Investigator Award" from the British Society of Rheumatology (2006), "First Prize for best research" from the British Pain Society (2007), and "President Award for best professor researcher" from KSAU-HS (2021).
Lastly, he is the editor in Chief of the Journal of Health Informatics in Developing Countries and an associate editor for BMC Health Services Research Journal.
Journal Club 6 (AY 2022-23)
Article for Discussion
Mechanical Valves Versus Ross Procedure for Aortic Valve Replacement in Children: Propensity Adjusted Comparison of Long-term Outcomes
Chair of the Session
Prof. Zohair Y. Al Halees
Distinguished Senior Pediatric and Congenital Heart Surgeon & Consultant,
Heart Center, King Faisal Specialist Hospital
& Research Centre, Riyadh
Adjunct professor of Surgery, Alfaisal University,
Riyadh, Saudi Arabia
President of the World Society for Pediatric and Congenital Heart Surgery
Dr. Al Halees held many positions within the King Faisal Specialist Hospital and Research Centre (KFSHRC) and was instrumental in establishing the department of cardiovascular diseases in 1987. This evolved into the King Faisal Heart Institute in 2003, and now known as the Heart Centre. He was appointed adjunct professor of Cardiac Surgery at the American University of Beirut Medical School, Lebanon since July 2013, where he frequently visits to perform complex cardiac surgeries. In addition, he holds the position of adjunct professor of surgery at Alfaisal University Medical School, Riyadh, Saudi Arabia (2016).
Dr. Al Halees is currently the President of World Society for Pediatric and Congenital Heart Surgery (WSPCHS) and a member of many national and international associations including the American Association for Thoracic Surgery (AATS), the Society of Thoracic Surgery (STS), the European Association for Cardiothoracic Surgery (EACTS), the European Heart Society, French Society for Cardiothoracic Surgeons, Gulf Heart Association, Pan Arab Congenital Heart Defects Association (PACHDA), Canadian Cardiovascular Society, Saudi Heart Association in addition to being an honorary member of many other Arabic and International Associations/Societies.
Dr. AlHalees sits on the editorial board of many peer-reviewed international cardiac journals like the Asian Cardiovascular and Thoracic Annals, Journal of Heart Valve Diseases and World Journal for Pediatric and Congenital Heart Surgery in addition to being on the advisory board of many others. He is often invited as a manuscript reviewer for various national and international cardiothoracic journals.
He published 426 articles and book chapters and 145 abstracts. He is a reviewer and member of the editorial board of various peer-reviewed international journals.
From the great works done by Dr. Halees, he received many recognitions and awards that included King Abdulaziz First Degree Medal of Honor, awarded to him directly from the hands of late King Abdullah Bin Abdulaziz.
Journal Club 7 (AY 2022-23)
Article for Discussion
Use of Warfarin and Risk of Urogenital Cancer: A Population-Based, Nested Case-Control Study
Chair of the Session
Prof. Hani Tamim
Professor of Medicine
Program Director, Master of Science in Health Research Management, College of Medicine, Alfaisal University,
Riyadh, Saudi Arabia
Dr. Hani Tamim received his Bachelor of Science in Biology from the American University of Beirut, Beirut, Lebanon in 1994. His Master of Public Health was obtained from Emory University, Atlanta, Georgia, USA in 1995. In 2003, he finished his Ph.D. at McGill University, Montreal, Quebec, Canada, with his dissertation on the effect of antidepressants on the risks of cancer development. Moreover, Dr. Tamim was enrolled in a two-year post-doctoral fellowship from the University of Montreal, Montreal, Quebec, Canada, with his major project being the effect of Proton Pump Inhibitors on the risk of gastric cancer. In 2005, he then took a post at the College of Medicine and King Abdullah International Medical Research Center at King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia, as an assistant professor of Epidemiology and Biostatistics. Between 2011 and 2021, he worked at the American University of Beirut as a professor, mainly directing the biostatistics unit at the Clinical Research Institute. Since September 2021, Dr. Tamim has been working at the College of Medicine at Alfaisal University in Riyadh, Saudi Arabia.
Dr. Tamim’s research interests include cancer research, pharmaco-epidemiology, research methodology, case-control studies, as well as statistical analyses of epidemiological data. Dr. Tamim’s publication record exceeds 500 publications and includes different disciplines, such as cancer, surgery, critical care, obstetrics and gynecology, quality of life, nephrology, and pediatrics, as well as other methodological papers. More specifically, his cancer publications are related to the effect of different drugs (antidepressants, antibiotics, warfarin, acid-suppressive drugs, etc.) on cancer development (breast cancer, prostate cancer, colorectal cancer, gastric cancer, urogenital cancers, etc.).
Journal Club 1 (AY 2023-24)
Article for Discussion
Post-transcriptional Screen of Cancer Amplified Genes Identifies ERBB2/Her2 Signaling As AU Rich mRNA Stability-Promoting Pathway.
Chair of the Session
Dr. Khalid AbouKhabar
Chairman of the Department of Molecular Biomedicine, King Faisal Specialist Hospital, and Research Center, Riyadh, KSA
Professor at Alfaisal University, Riyadh, KSA
Adjunct staff at the Lerner Research Institute in the Cleveland Clinic, Ohio, USA
Dr. Khalid S. Abu Khabar received his Ph.D. from the University of Pittsburgh (USA) in 1993 with the U.S. National Delta Omega Honor. He was trained in molecular immunology and established his laboratory in 1993 at King Faisal Specialist Hospital and Research Centre (KFSHRC), where he rose to Principal Senior Scientist in 2011. Today, he is Chairman of the Department of Molecular Biomedicine and former Deputy Executive Director of the Research Centre (2013-2022). He is also a Professor at Alfaisal University, where he founded the postgraduate program for molecular/cellular biology. He has been an adjunct staff at Lerner Research Institute in Cleveland Clinic (U.S.) since 2000.
He has published over 80 full-length original papers with more than 50 citations per paper and delivered many international talks, including plenary sessions. He received the first US NIH funding (subcontract) to Saudi Arabia and is a grant reviewer for international agencies, including US-NSF and UK-MRC. Dr. Khabar has over 16 granted patents covering tools/applications for mRNA decay in precision medicine and biotechnology. He has also been a board member of biotechnology initiatives in Saudi Arabia, such as the National Strategy for Research Priorities and the King Saud University Biotechnology Centre. Dr. Khabar has received funding for a biotech venture at KFHSRC, along with several awards, including the ICTT Award (UICC), the first Outstanding Scientist Award (KFSHRC), and the King’s Award for Inventors and Talents.
Dr. Khabar is a renowned expert in the field of "AU-rich Elements" which are mRNA decay sequence determinants. He ranks among the top five authors according to Scopus/Web of Science field search. He broadened this field by discovering ~4000 AU-rich mRNAs. He then investigated their global impact on inflammation and cancer and studied their interactions with RNA-binding proteins (TTP and HuR). He showed that TTP induces anti-mitotic/invasion activity by binding and modulating cancer AU-rich mRNAs while demonstrating the loss of this activity in solid tumors. He recently performed the largest screen for kinase inhibitors in post-transcriptional control. Previously, he identified the first cellular mRNA target for RNase L, otherwise known for its antiviral mRNA activity, and further identified key mechanistic interactions with other RNA-binding proteins that affect cellular growth.
Journal Club 2 (AY 2023-24)
Article for Discussion
Antiviral Therapy Substantially Reduces HCC Risk in Patients with Chronic Hepatitis B Infection in the Indeterminate Phase
Chair of the Session
Dr. Faisal Abaalkhail
Consultant in Gastroenterology and Hepatology at KFSH&RC, Riyadh
Professor at Alfaisal University, Riyadh, KSA
President of the Saudi Society of the Study of Liver & Transplantation (SASLT)
Governor of the American College of Physicians Saudi Chapter
Dr. Faisal Abaalkhail is a consultant in Gastroenterology and Hepatology at King Faisal Specialist Hospital & Research Centre, Riyadh. He has also worked as a Transplant Hepatologist (since 2008) in the same hospital. He then became the Chairman of Liver Transplant at King Fahad Specialist Hospital in 2018. Dr. Faisal obtained a Master's in Health Management at McGill University, Montreal, Canada.
Furthermore, he is the president of the Saudi Society of the Study of Liver & Transplantation (SASLT) and the current governor of the American College of Physicians (ACP) Saudi Chapter. In addition to that, Dr. Faisal also worked as a consultant at Health Holding Company and in the Ministry of Health. He is also a Professor in the College of Medicine, Alfaisal University.
Journal Club 3 (AY 2023-24)
Article for Discussion
A New Score Combining Compound Muscle Action Potential (CMAP) Amplitudes and Motor Score is Predictive of Motor Outcome After AVXS-101 (Onasemnogene Abeparvovec) SMA Therapy
Chair of the Session
Dr. Ali Alshehri
Deputy Executive Director, Academic & Training Affairs,
Director of the Neuromuscular Integrated Practice unit, KFSH&RC, Riyadh
Dr. Ali Alshehri holds the position of Deputy Executive Director of Academic and Training Affairs and also serves as the Director of the Neuromuscular Integrated Practice unit at King Faisal Specialist Hospital and Research Center. He is an Assistant Professor of Neurology with extensive experience in neuromuscular medicine.
Additionally, he is the President of the Saudi Arabia Neuromuscular Medicine & Electrodiagnostic Chapter (SANEM). Dr. Alshehri is the Chairman and member of several educational and quality improvement committees and possesses profound electrophysiological skills in nerve conduction study, electromyography, single-fiber electromyography, and autonomic studies.
Journal Club 4 (AY 2023-24)
Article for Discussion
Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis
Chair of the Session
Dr. Afaf Al Sagheir
Chairman of the Paediatrics Research Unit
Consultant in Pediatric Endocrinology /Diabetes, KFSH&RC, Riyadh
Assistant Professor, Alfaisal University, Riyadh
Dr. Afaf Al Sagheir serves as the Chairman of the Paediatrics Research Unit and consultant in Pediatric Endocrinology/Diabetes at KFSHRC, Riyadh, KSA. She is also an Assistant Professor at Alfaisal University, College of Medicine.
Dr. Al Sagheir is an accomplished medical professional specializing in Pediatric Endocrinology and Diabetes with a wealth of experience in the field. She completed her medical education at King Saud University and pursued her specialization in Paediatrics, obtaining certification from the Saudi Board of Paediatrics from the Saudi Medical Council. She then completed an Endocrinology Fellowship at McMaster University.
Throughout her career, Dr. Al Sagheir has demonstrated a diligent commitment to research, having made significant contributions to the field, and holds memberships in professional organizations and societies.
Journal Club 5 (AY 2023-24)
Article for Discussion
Trofinetide for the Treatment of Rett Syndrome: A Randomized Phase 3 Study
Chair of the Session
Dr. Hesham Aldhalaan
Consultant of the Integrated Practice Unit in Epilepsy and assigned as the Director of the Autism Center (from November 2013 to present) at King Faisal Specialist Hospital & Research Centre, Riyadh. He has been receiving awards for the Comprehensive Epilepsy Program
Dr. Hesham Aldhalaan obtained his M.D. from King Saud University, College of Medicine. He started his profession by gaining certificates and licenses from prestigious institutions such as the American Board of Pediatrics, Royal College of Physician and Surgeons of Canada in Pediatric, Royal College of Physicians and Surgeons of Canada in Neurology, Certificate of Training in Epilepsy and EEG from University of Western Ontario, London. ON, Canada, diploma in Neurophysiology from the Canadian Society of Neurophysiologists, Certificate of Saudi Commission Professional Registration, Clinical Fellowship in Intraoperative Neurophysiologic Monitoring, and University of British Columbia, Vancouver, Canada.
Eventually, he earned his position as a Consultant Pediatric Neurologist at King Faisal Specialist Hospital & Research Centre, Riyadh, KSA, and was assigned to the following positions: Section Head of Pediatric Neurology between 2005 and 2007, Director of EEG Technologist Training Program until September 2013, Director of Pediatric Neurology Residency Program, Chairman of Pediatric Neurology Residency Program at Saudi Commission for Health Sciences and Director of Epilepsy Fellowship program.
Dr. Dhalaan is currently a Consultant of the Integrated Practice Unit in Epilepsy and assigned as the Director of the Autism Center (from November 2013 to present) at King Faisal Specialist Hospital & Research Centre, Riyadh. He has been receiving awards for the Comprehensive Epilepsy Program. He is an active member of different committees in the hospital. He did numerous regional, national, and international presentations and did several publications. He is currently an active member of a fellow of RCPSC in Pediatric and Neurology, AAN, Canadian Child Neurology Society, Saudi Pediatric Neurology Society, and Saudi Pediatric Society.
Journal Club 6 (AY 2023-24)
Article for Discussion
Knowledge of HIV/AIDS transmission modes and attitudes toward HIV/AIDS infected people and the level of HIV/AIDS awareness among the general population in the Kingdom of Saudi Arabia: A cross-sectional study
Chair of the Session
Dr. Nezar Bahabri
Consultant, Internal Medicine & Infectious Diseases,
Director of the Internal Medicine Department,
Dr. Soliman Fakeeh Hospital (DSFH), Jeddah, KSA
Director of the Saudi Society of Microbiology & Infectious Disease, Al-Khobar, KSA
Dr. Nezar Bahabri is a distinguished figure in the fields of internal medicine and infectious diseases, with a career spanning both academic excellence and impactful public health education. His journey began with earning a Bachelor’s in Medicine and Surgery in 1998 from the College of Medicine at King Faisal University in Dammam, Saudi Arabia. His academic pursuits led him to the University of British Columbia, where he obtained the American Board of Internal Medicine (ABIM) certificate in 2007 and was honoured with the Best Resident Doctor award for his exceptional contributions to medical education.
Furthering his specialization, Dr. Bahabri completed a fellowship with the Royal College of Physicians in Canada in 2008 and obtained an Infectious Diseases Certificate from the American Board of Internal Medicine in 2010. His internal medicine and infectious diseases expertise is recognised through his dual board certifications in the United States and Canada.
Since 2012, Dr. Bahabri has been the director of the Saudi Society of Microbiology and Infectious Disease, where he has played a pivotal role in advancing the society’s research and public health initiatives. His scholarly work includes over 20 publications, enriching the field with his research and insights.
Beyond his professional achievements, Dr. Bahabri has leveraged social media to become a leading health educator and influencer, amassing over 1 million followers and 80 million views of his medical content in 2023 alone. Establishing an engaging online presence, he has effectively raised public awareness of crucial health issues, making complex medical information accessible to a broad audience.
Contact Info
You are welcome to contact us at iocom@alfaisal.edu any time should you have questions.